文献速递糖尿病肥胖与代谢综合征

糖尿病前期回归正常血糖与心血管代谢危险因素对2型糖尿病风险的作用

Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes.
PubMed 文献 · Diabetologia · 2025-10-18

该研究基于美国、澳大利亚和亚洲的前瞻性队列数据,纳入基线糖尿病前期且至少两次随访的8191名个体,分析回归正常血糖与后续2型糖尿病风险的关系。结果显示,回归正常血糖者2型糖尿病风险降低51%,合并有利心血管代谢因素者风险更低。

要点

  • 糖尿病前期回归正常血糖与2型糖尿病风险降低51%相关。
  • 合并不吸烟、正常BMI、腰围、血压、血脂等有利因素时风险进一步降低。
  • 体重减轻联合回归正常血糖也降低2型糖尿病风险。

核心结论

  • 在糖尿病前期阶段优先促进血糖回归正常可能有助于降低2型糖尿病风险,尤其当伴随有利的心血管代谢健康指标时。

研究设计与样本

  • 研究使用美国、澳大利亚和亚洲的前瞻性队列个体水平数据,纳入基线糖尿病前期且至少两次随访的8191名参与者,中位随访间隔分别为2.9年和3.1年。

主要发现

  • 与持续糖尿病前期相比,回归正常血糖与2型糖尿病风险降低51%相关。
  • 合并不吸烟(HR 0.20,95% CI 0.10, 0.31)、正常BMI(0.16,95% CI 0.06, 0.27)、正常腰围(0.22,95% CI 0.12, 0.33)、正常腰高比(0.15,95% CI 0.03, 0.26)、正常腰臀比(0.17,95% CI 0.05, 0.28)、正常收缩压(0.20,95% CI 0.11, 0.30)和舒张压(0.25,95% CI 0.12, 0.38)、正常甘油三酯(0.24,95% CI 0.13, 0.35)及正常HDL胆固醇(0.21,95% CI 0.13, 0.29)时风险更低。
  • 体重减轻联合回归正常血糖与2型糖尿病风险降低相关(0.18,95% CI 0.07, 0.30), compared with weight gain and persistent prediabetes。

临床怎么用

  • 临床应重视糖尿病前期患者血糖回归正常的干预,并综合管理心血管代谢危险因素以进一步降低2型糖尿病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We aimed to investigate the association between reversion to normoglycaemia among individuals with prediabetes (fasting plasma glucose 5.6-6.9 mmol/l in the absence of other criteria for type 2 diabetes) and the subsequent risk of type 2 diabetes, and to examine whether concurrent favourable cardiometabolic risk factor profiles modify this association. METHODS: We used individual-level data from prospective cohorts in the USA, Australia and Asia. Participants with prediabetes at baseline, with at least two follow-ups (n=8191) at median intervals of 2.9 years (IQR 2.3-9.0) and 3.1 years (IQR 2.6-3.6), were classified into restoration of normoglycaemia and persistent prediabetes groups based on the glucose status at the first follow-up (normoglycaemia or prediabetes). Type 2 diabetes occurrence was assessed at subsequent follow-ups. Hierarchical mixed-effects proportional hazards Weibull models estimated type 2 diabetes risk, adjusting for age, sex and cardiometabolic risk factors. A subgroup analysis evaluated the combined association of normoglycaemia restoration and normal cardiometabolic risk factor levels on subsequent type 2 diabetes risk. RESULTS: In individuals with prediabetes, normoglycaemia restoration compared with persistent prediabetes was associated with a 51% lower risk of developing type 2 diabetes. Even lower risks were observed among individuals with concurrent favourable cardiometabolic profiles, including non-smokers (HR 0.20, 95% CI 0.10, 0.31), and those with normal BMI (0.16, 95% CI 0.06, 0.27), waist circumference (0.22, 95% CI 0.12, 0.33), waist-to-height ratio (0.15, 95% CI 0.03, 0.26), WHR (0.17, 95% CI 0.05, 0.28), and systolic (0.20, 95% CI 0.11, 0.30) and diastolic (0.25, 95% CI 0.12, 0.38) blood pressure, triacylglycerol (0.24, 95% CI 0.13, 0.35) and HDL-cholesterol levels (0.21, 95% CI 0.13, 0.29). Weight loss combined with normoglycaemia restoration was also associated with lower type 2 diabetes risk (0.18, 95% CI 0.07, 0.30) compared with weight gain and persistent prediabetes. CONCLUSIONS/INTERPRETATION: Our results suggest that prioritising normoglycaemia restoration during the prediabetes stage in clinical guidelines may contribute to reducing the risk of type 2 diabetes, particularly when accompanied by favourable cardiometabolic health profiles.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Davoodian N, Lotfaliany M, Huxley RR, et al. Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes. Diabetologia. 2025. PMID: 41107618. doi:10.1007/s00125-025-06555-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。